Raymond J Chan1,2, Doris Howell3, Maryam B Lustberg4, Karen Mustian5, Bogda Koczwara6, Chiu Chin Ng7, Yoon Kim8, Anna María Nápoles9, Niharika Dixit10, Dori Klemanski11, Yu Ke7, Yi Long Toh7, Margaret I Fitch12, Megan Crichton13, Sangeeta Agarawal14, Alexandre Chan15. 1. School of Nursing and Cancer and Palliative Care Outcomes Centre, Queensland University of Technology, Level 3, N Block, Brisbane, 4059, Australia. Raymond.Chan@qut.edu.au. 2. Division of Cancer Services, Princess Alexandra Hospital, Metro South Hospital and Health Services, Brisbane, Australia. Raymond.Chan@qut.edu.au. 3. Department of Supportive Care, Princess Margaret Cancer Research Center and Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Canada. 4. College of Medicine, The Ohio State Comprehensive Cancer Center, Columbus, OH, USA. 5. Department of Surgery, Wilmot Cancer Institute, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, NY, USA. 6. Department of Medical Oncology, Flinders Medical Centre, Flinders University, Adelaide, Australia. 7. Department of Pharmacy, National University of Singapore, Singapore, Singapore. 8. Department of Physical Medicine and Rehabilitation, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. 9. Division of Intramural Research, National Institute on Minority Health and Health Disparities, National Institutes of Health, Bethesda, MD, USA. 10. Department of Medicine, Division of Hematology and Oncology, University of California San Francisco/Zuckerberg San Francisco General Hospital, San Francisco, CA, USA. 11. Wexner Medical Center, The Ohio State University, Columbus, OH, USA. 12. Lawrence S. Bloomberg, Faculty of Nursing, University of Toronto, Toronto, Canada. 13. School of Nursing and Cancer and Palliative Care Outcomes Centre, Queensland University of Technology, Level 3, N Block, Brisbane, 4059, Australia. 14. Helpsyhealth.com and University of California San Francisco, San Francisco, CA, USA. 15. Department of Clinical Pharmacy Practice, Susan and Henry Samueli College of Health Sciences, University of California, Irvine, 101 Theory, Suite 100, Irvine, CA, 92697-3958, USA. a.chan@uci.edu.
Abstract
PURPOSE: The role of mobile health (mHealth) technology in cancer care has evolved alongside the rapid development in digital technology. Its use can come with significant potential benefits; however, such use may also be associated with risks. This paper summarizes the latest developments around mHealth use in cancer care presented by a panel of experts at the 2019 Annual Meeting of the Multinational Association of Supportive Care in Cancer. METHODS: Through lectures, case studies, and panel discussions, speakers and participants (including cancer specialist doctors, nurses, and allied health professionals) evaluated current and emerging mHealth methods for supportive care in cancer survivorship. Focus areas and special considerations were agreed upon by consensus. RESULTS: Three focus areas for the use of mHealth in cancer care were identified: activation and support of self-management, exercise oncology, and enablement of survivorship care delivery. In addition to these focus areas, two special considerations were highlighted: technology-enhanced supportive cancer care for disparate populations, and ethical considerations relevant to the use of technology in supportive care. CONCLUSION: mHealth has the potential to revolutionize and transform cancer care delivery. Future research should guide further advances in the use of technology in supportive cancer care and carefully explore the safety, efficacy, cost-effectiveness, and implementation of interventions delivered through mHealth platforms.
PURPOSE: The role of mobile health (mHealth) technology in cancer care has evolved alongside the rapid development in digital technology. Its use can come with significant potential benefits; however, such use may also be associated with risks. This paper summarizes the latest developments around mHealth use in cancer care presented by a panel of experts at the 2019 Annual Meeting of the Multinational Association of Supportive Care in Cancer. METHODS: Through lectures, case studies, and panel discussions, speakers and participants (including cancer specialist doctors, nurses, and allied health professionals) evaluated current and emerging mHealth methods for supportive care in cancer survivorship. Focus areas and special considerations were agreed upon by consensus. RESULTS: Three focus areas for the use of mHealth in cancer care were identified: activation and support of self-management, exercise oncology, and enablement of survivorship care delivery. In addition to these focus areas, two special considerations were highlighted: technology-enhanced supportive cancer care for disparate populations, and ethical considerations relevant to the use of technology in supportive care. CONCLUSION: mHealth has the potential to revolutionize and transform cancer care delivery. Future research should guide further advances in the use of technology in supportive cancer care and carefully explore the safety, efficacy, cost-effectiveness, and implementation of interventions delivered through mHealth platforms.
Entities:
Keywords:
Cancer; Mobile health; Oncology; Survivorship; Technology; mHealth
Authors: Annie M Young; Fredrick D Ashbury; Lidia Schapira; Florian Scotté; Carla I Ripamonti; Ian N Olver Journal: Support Care Cancer Date: 2020-09 Impact factor: 3.603
Authors: Linda Watson; Siwei Qi; Andrea Delure; Claire Link; Eclair Photitai; Lindsi Chmielewski; April Hildebrand; Dean Ruether; Krista Rawson Journal: JCO Oncol Pract Date: 2021-08-05